HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus. [electronic resource]
Producer: 20090401Description: 745-52 p. digitalISSN:- 1527-3350
- Animals
- Antiviral Agents -- pharmacology
- Benzofurans -- pharmacology
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Therapy, Combination
- Enzyme Inhibitors -- pharmacology
- Hepacivirus -- drug effects
- Hepatitis C -- drug therapy
- Hepatocytes -- transplantation
- Humans
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Liver -- drug effects
- Mice
- Mice, SCID
- Polyethylene Glycols
- Recombinant Proteins
- Replicon -- drug effects
- Ribavirin -- therapeutic use
- Sulfonamides -- pharmacology
- Viral Nonstructural Proteins -- antagonists & inhibitors
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.